Clinical trial
Effect of Caloric Restriction on Metabolic Biomarkers and Fat Oxidation in Obese Men and Women (Magellan II)
NCT01616082 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Caloric Restriction on Metabolic Biomarkers and Fat Oxidation in Obese Men and Women (Magellan II)
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- November 30, 2012
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.